Join
Live feed
·
INSIDERFilingvia Quantisnow
Akero Therapeutics Inc. logo

Chief Financial Officer White William Richard sold $151,402 worth of shares (2,804 units at $53.99), decreasing direct ownership by 5% to 59,155 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AKRO· Akero Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKRO (Akero Therapeutics Inc.) and more on Quantisnow.